Quantitative Neuromuscular Monitoring and Gastric Bypass Surgery

a study on Sugammadex Gastric Bypass

Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.

Official Title

A Before/After Study of the Impact of Quantitative Neuromuscular Monitoring and Sugammadex Reversal Following Gastric Bypass Surgery

Keywords

Sugammadex, Quantitative Neuromuscular Function Monitoring

Eligibility

You can join if…

Open to people ages 18 years and up

  • age greater than 18 years
  • scheduled for an elective laparoscopic gastric bypass procedure

You CAN'T join if...

  • age less than 18 years
  • pregnancy
  • prisoners
  • significant co-existing lung disease including asthma or chronic obstructive pulmonary disease (COPD) requiring regular medication
  • patients who require supplemental oxygen pre-operatively to maintain a hemoglobin saturation (SpO2>98%)

Location

  • UC Davis Medical Center accepting new patients
    Sacramento California 95817 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Davis
ID
NCT05886218
Study Type
Observational
Participants
Expecting 215 study participants
Last Updated